Jan 20 (Reuters) - Novavax ‌said on ‌Tuesday it was ⁠entering ‌into a ‍licensing agreement with Pfizer ‌to develop vaccine products ⁠for infectious diseases. I stopped shopping for a year and saved $6 ...

They aren't just "pandemic stocks." ...

Pfizer (NYSE:PFE) has started a Phase 1 trial of a new tafamidis tablet formulation aimed at improving manufacturing ...

Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...

The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million, marking a major policy shift under Secretary Robert F. Kennedy Jr. that directly affects ...

Pfizer Inc (NYSE:PFE) develops medicines and vaccines across multiple therapeutic areas, contributing to the S&P 500 ...

The announcement Monday from Pfizer and its German partner BioNTech that their coronavirus vaccine appears to be 90% effective thrilled medical experts around the world and presented a glimmer of hope ...

(Reuters) -Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine ‌to combat the ...

Pfizer has reached a turning point.

Pfizer CEO Albert Bourla on Wednesday defended the development of Covid vaccinations, including Pfizer’s own, suggesting that they should have won President Trump a Nobel Peace Prize, in response to a ...

Anxiety is high among parents as more kids head back to school without the protection of a COVID-19 vaccine for at least a few more months. Parents have a reason to be concerned. After months of ...